Author:
Schilit Samantha L.P.,Schilit Nitenson Arielle
Funder
National Science Foundation
Reference18 articles.
1. Ayuso, C., Millan, J. M., Mancheno, M., & Dal-Re, R. (2013). Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process. European Journal of Human Genetics, 21(10), 1054–1059. doi: 10.1038/ejhg.2012.297 .
2. Christensen, K. D., Dukhovny, D., Siebert, U., & Green, R. C. (2015). Assessing the costs and cost-effectiveness of genomic sequencing. Journal of Personalized Medicine, 5(4), 470–486. doi: 10.3390/jpm5040470 .
3. Cordero, P., & Ashley, E. A. (2012). Whole-genome sequencing in personalized therapeutics. Clinical Pharmacology and Therapeutics, 91(6), 1001–1009. doi: 10.1038/clpt.2012.51 .
4. Genetic Information Nondiscrimination Act of 2008, Pub. L. 110-223, 122 Stat. 881, codified as amended in scattered sections of 26, 29, and 42 U.S.C. https://www.gpo.gov/fdsys/pkg/PLAW-110publ233/html/PLAW-110publ233.htm . Accessed date May 6, 2016.
5. Godard, B., Hurlimann, T., Letendre, M., Egalite, N., & INHERIT BRCAs (2006). Guidelines for disclosing genetic information to family members: from development to use. Familial Cancer, 5(1), 103–116. doi: 10.1007/s10689-005-2581-5 .
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献